Home Newsfeeds Goldman Sachs Downgrades DigitalOcean Holdings to Sell, Lowers Price Target to $40

Goldman Sachs Downgrades DigitalOcean Holdings to Sell, Lowers Price Target to $40

Goldman Sachs analyst Gabriela Borges downgrades DigitalOcean Holdings (NYSE:DOCN) from Buy to Sell and lowers the price target from $54 to $40.

byBenzinga Newsdesk

July 13, 2022

1 minute read

Goldman Sachs analyst Gabriela Borges downgrades DigitalOcean Holdings (NYSE:DOCN) from Buy to Sell and lowers the price target from $54 to $40.

$2.8M Bet On This Healthcare Stock? Check Out These 4 Stocks Insiders Are Buying

By Lisa Levin

October 31, 6:34 AM

Although U.S. stocks closed higher on Monday, there were a few notable insider trades.

KDP

A Congressman Just Sold JPMorgan Stock Ahead Of Earnings: See Two Dividend Stocks He Is Also Trading

By Robert Kuczmarski

October 11, 11:45 AM

Congressman Earl Blumenauer (D-Ore.) has served as the U.S. Representative for Oregon's 3rd congressional district since 1996.

ALK

Predicine Announces Collaboration With Janssen To Develop PredicineCARE As A Companion Diagnostic Assay In Localized Bladder Cancer

By Benzinga Newsdesk

January 8, 1:08 PM

Collaboration Utilizing PredicineCARE™ Urine cfDNA NGS Assay Marks Progress in Employing Comprehensive Genomic Profiling for Detection of Select Alterations in Localized Bladder CancerPredicine, Inc., a leading

JNJ

Park-Ohio Hldgs Q4 EPS $0.85 Beats $0.46 Estimate, Sales $382.00M Miss $427.10M Estimate

By Happy Mohamed

March 15, 4:39 PM

Park-Ohio Hldgs (NASDAQ:PKOH) reported quarterly earnings of $0.85 per share which beat the analyst consensus estimate of $0.46 by 84.78 percent. This is a 178.7 percent increase over losses of $(1.08) per share from the

PKOH

Goldman Sachs Downgrades DigitalOcean Holdings to Sell, Lowers Price Target to $40

Related Posts

$2.8M Bet On This Healthcare Stock? Check Out These 4 Stocks Insiders Are Buying

A Congressman Just Sold JPMorgan Stock Ahead Of Earnings: See Two Dividend Stocks He Is Also Trading

Predicine Announces Collaboration With Janssen To Develop PredicineCARE As A Companion Diagnostic Assay In Localized Bladder Cancer

Park-Ohio Hldgs Q4 EPS $0.85 Beats $0.46 Estimate, Sales $382.00M Miss $427.10M Estimate